OptiNose, Inc. announced preliminary XHANCE net product revenue results for the first quarter ended March 31, 2024. for the quarter, the company reported preliminary XHANCE net product revenue of $14.9 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.14 USD | +12.87% | +32.68% | -11.63% |
Apr. 25 | OptiNose, Inc. Provides Revenue Guidance for the First Quarter of 2024 | CI |
Apr. 25 | Transcript : OptiNose, Inc. - Special Call |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.63% | 129M | |
+31.52% | 690B | |
+21.96% | 546B | |
-5.21% | 358B | |
+17.02% | 323B | |
+5.01% | 287B | |
+13.68% | 235B | |
+3.81% | 199B | |
-10.63% | 195B | |
+3.98% | 161B |
- Stock Market
- Equities
- OPTN Stock
- News OptiNose, Inc.
- Optinose, Inc. Announces Preliminary XHANCE Net Product Revenue Results for the First Quarter Ended March 31, 2024